Autoimmune Movement Disorders: a Clinical and Laboratory Approach.

Abstract

Autoimmune movement disorders are caused by an aberrant immune response to neural self-antigens. These disorders may be paraneoplastic, parainfectious, or (most commonly) idiopathic. The neurological presentations are diverse, and sometimes multifocal. Movement disorders can occur as part of the spectrum with phenotypes including chorea, myoclonus, ataxia, CNS hyperexcitability (including stiff-person syndrome), dystonia, and parkinsonism. Symptoms are subacute in onset and may have a fluctuating course. The best characterized disorders are unified by neural autoantibodies identified in serum or cerebrospinal fluid. The antibody specificity may predict the association with cancer and the response to immunotherapy. In this article, we review autoimmune-mediated movement disorders, associated cancers, diagnosis, and treatment.

• Authors: Josephe Archie Honorat, Andrew McKeon
• Journal: Current neurology and neuroscience reports (Curr Neurol Neurosci Rep) Vol. 17 Issue 1 Pg. 4 (01 2017) ISSN: 1534-6293 [Electronic] United States
• PMID: 28120141 (Publication Type: Journal Article, Review)

Chemical References

• Autoantibodies
• Autoantigens

Topics

• Autoantibodies (immunology)
• Autoantigens (immunology)
• Autoimmune Diseases (immunology, therapy)
• Humans
• Immunologic Tests
• Immunotherapy
• Movement Disorders (diagnosis, immunology, therapy)